过去 18 个月，Scholl Hendrik Peter（CIK 2113223）在 1 家公司共报告 13 笔 SEC Form 4 内部人交易（最近一笔 2026-06-22）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 96 | $13,814 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 3,748 | $542,186 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 4,861 | $706,935 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 1,199 | $175,342 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 96 | $14,123 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 2,054 | $282,651 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 784 | $108,333 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 3,140 | $438,250 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 540 | $75,913 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 100 | $14,183 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 450 | $63,990 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 1,897 | $272,314 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | 卖出 | 1,035 | $150,096 |
来源：SEC Form 4 申报文件 · 截至 2026-06-22